11.12.2024

Thema: Asthma and Allergy Foundation of America

AAFA

December Research Update: Impact of Changing Inhaler Market on Asthma, Air Pollution, and Solar...

Welcome to our December research update! Getting involved with research is an important way to impact asthma and allergy treatments, education, and awareness. This...
AAFA

Coronavirus (COVID-19): What People With Asthma Need to Know

COVID-19 is a disease caused by a virus called SARS-CoV-2 (a type of coronavirus). It causes respiratory symptoms, but it can also affect other...
AAFA

Living with Nasal Polyps: Real-Life Perspectives

Chronic rhinosinusitis is a common medical condition that affects 5-12% of adults. 1 Around 20 to 30% of people with chronic rhinosinusitis have nasal...
AAFA

October Research Update: New Treatment Options, Impact of Environment on Asthma and Allergies

Welcome to our October research update! Getting involved with research is an important way to impact asthma and allergy treatments, education, and awareness. This month, we are highlighting clinical trials, surveys...
AAFA

People With Asthma and Allergies Need to Take Precautions During Cleanup After a Flood

After a natural disaster with flooding, people with asthma and allergies need to take extra precautions as they begin cleanup efforts. Long after waters...
AAFA

Steps to Improve Your Home’s Indoor Air Quality

Did you know people spend as much as 90% of their time inside their homes, offices, schools, and cars? 1 For people with allergies...
AAFA

Biologics 101: Treatment Options for Asthma, Food Allergies, Eczema, and More (Webinar)

Navigating the world of biologics can be complicated. But it doesn't have to be! If you’ve tried treatments for our asthma, food allergies, eczema,...
AAFA

2024 Asthma Capitals™ Report: How Location Can Impact Asthma

AAFA’s 2024 Asthma Capitals™ Report Highlights the Most Challenging Places in the U.S. to Live with Asthma The Asthma and Allergy Foundation of America...
AAFA

FDA Approves neffy® Epinephrine Nasal Spray for Treating Severe Allergic Reactions

Epinephrine is the first-line treatment for severe allergic reactions, but far too often, people do not use or get it when needed. The FDA’s...
AAFA

Ask Congress to Support the Indoor Air Quality and Healthy Schools Act

Students are healthier and learn better when their indoor air is cleaner. When children don’t have asthma symptoms triggered by poor air quality, they...